Entry |
|
Name |
Morinamide (INN) |
Formula |
C10H14N4O2
|
Exact mass |
222.1117
|
Mol weight |
222.24
|
Structure |

|
Class |
|
Remark |
|
Efficacy |
Antibacterial (tuberculostatic) |
Comment |
Pyrazinamide derivative
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J04 ANTIMYCOBACTERIALS
J04A DRUGS FOR TREATMENT OF TUBERCULOSIS
J04AK Other drugs for treatment of tuberculosis
J04AK04 Morinamide
D07248 Morinamide (INN)
Drug groups [BR:br08330]
Antibacterial
DG01966 Antitubercular
DG02009 Pyrazinamide derivative
D07248 Morinamide
Antimicrobials [BR:br08307]
Antibacterials
Bactericidal action
Pyrazinamide
D07248 Morinamide (INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 16
1 C8x C 22.0378 -18.3954
2 C8x C 22.0378 -19.7942
3 N5x N 23.2491 -20.4935
4 C8x C 24.4605 -19.7942
5 C8y C 24.4605 -18.3954
6 N5x N 23.2491 -17.6961
7 C5a C 25.6969 -17.6961
8 N1b N 26.9083 -18.3954
9 C1b C 28.1197 -17.6961
10 N1y N 29.3310 -18.3954
11 C1x C 29.3310 -19.7941
12 C1x C 30.5424 -20.4934
13 O2x O 31.7537 -19.7941
14 C1x C 31.7537 -18.3954
15 C1x C 30.5424 -17.6961
16 O5a O 25.7031 -16.2976
BOND 17
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 5 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 10 11 1
12 11 12 1
13 12 13 1
14 13 14 1
15 14 15 1
16 10 15 1
17 7 16 2
|